Cardiac amyloidosis (CA) is a serious condition that results in infiltrative cardiomyopathy
and heart failure with preserved ejection fraction (HFpEF) that is caused by the extracellular …

Heart failure is a devastating syndrome affecting an increasingly high number of patients
worldwide. Its aetiology and pathogenesis are complex with the involvement of factors …

Aims Wild‐type transthyretin cardiac amyloidosis (ATTRwt CA) is a common,
underdiagnosed cause of heart failure (HF) in the elderly. Concurrent extracardiac amyloid …

Aims Cardiac amyloidosis (CA) is a potentially fatal multisystemic disease that remains
significantly underdiagnosed, particularly in the Middle East. This study aims to evaluate the …

Background Diagnosis of cardiac amyloidosis (CA) is often delayed due to variability in
clinical presentation. The electrocardiogram (ECG) is one of the most common and widely …

Background and objectives Cardiac amyloidosis (CA) is a common pathology in elderly
patients that usually presents as heart failure (HF). However, it is not clear whether CA …

Background: Amyloidosis is a disease of increasing interest, primarily due to its high
prevalence and advances in diagnostic and therapeutic options. It is known to be coexistent …

Antecedentes y objetivos La amiloidosis cardiaca (AC) es una patología frecuente en
pacientes ancianos que suele manifestarse como insuficiencia cardiaca (IC). Sin embargo …

Background Patients with cardiac amyloidosis (CA) often experience heart failure (HF)
episodes. No evidence is available on inotropic therapy. This study aims to fill this gap by …